Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis.
about
Probiotics for patients with hepatic encephalopathyProbiotics for hepatic encephalopathyEvaluation of the impact of rehospitalization in the management of hepatic encephalopathyType and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study.A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With CirrhosisUtility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom.Factors influencing health-related quality of life in chronic liver disease.Disease-specific health-related quality of life and its determinants in liver cirrhosis patients in Lithuania.Translation and validation of the Greek chronic liver disease questionnaireMini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study.Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis.Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.Minimal hepatic encephalopathy impairs quality of life.Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs.Cognition in liver disease.Chronic liver disease questionnaire: translation and validation in ThaisCovert and Overt Hepatic Encephalopathy: Diagnosis and ManagementHealth-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist.The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis.Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China.Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.Cognitive function does not worsen during long-term low-dose peginterferon therapy in patients with chronic hepatitis CImpact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.Rifaximin in the treatment of hepatic encephalopathy.Illness apprehension, depression, anxiety, and quality of life in liver transplant candidates: implications for psychosocial interventions.Factors affecting health-related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre study.PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis.Clinical management of hepatic encephalopathy.Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responsesA current review of the diagnostic and treatment strategies of hepatic encephalopathy.Palliative care for patients with end-stage liver disease.Management of covert hepatic encephalopathy.Probiotics for people with hepatic encephalopathy.The impact of hepatitis C virus outside the liver: Evidence from Asia.Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease.The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α.Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis.
P2860
Q24235259-7AACA064-0159-4A50-9096-F854EB24489EQ24236083-BFD6A8AF-7B05-4EF7-AA0F-06D13713CEA9Q28085014-E5EF0C9A-912F-4D0D-8DDC-F1973D3F2B94Q33376874-FB9DF1D7-BD52-41E0-BDDA-199AEAD48E6BQ33572343-E53A5720-98AA-418B-B17D-BAE35BE27CEEQ33805568-5694D786-5642-435D-A570-CD8B82EC385CQ33866690-DF81DC54-5F60-4C74-84EC-CA1548FD985BQ33866695-CC951A6F-780C-4DDF-809C-3D9E12C0CE7EQ34406478-CE601465-A695-4FB1-ADD6-316F397D251EQ34787750-89708760-8433-455E-86BA-67D28B6065BEQ34823693-1A17DA19-59F3-4A09-A193-FE1528588AA6Q35498468-4A8ED58A-4341-461D-B089-603576D7CDA1Q35642834-23EA2141-05B9-44F6-8265-7A35FDE8EBE3Q35862181-DDD7F3B1-4501-4B1B-B64F-4CA0A96D81A1Q36033362-8DEFC46B-06EF-4C02-B193-B2F0DA459427Q36065914-7AD4C230-40FF-4878-BBF6-192AAFBDD9BFQ36199772-A5280CFB-D94D-498E-9A4C-082CA56BED57Q36310606-D535EF78-C08C-4D9F-AC4E-57F5D4E16BCCQ36947936-E9A8A71B-077B-4931-AE96-48D5E3A9C16BQ36958236-61194C37-B2E0-40D0-8E64-CDC06213B8CCQ37087534-9E867C65-EE5F-42A1-8C9A-7F3DB322E028Q37107261-64D56B1D-69BB-4D3E-9B7E-ED4A6BFB2D98Q37169161-25795339-A94B-446B-979A-322D66014D15Q37353473-AB942C3A-A88F-49B9-9C7A-3A349315E584Q37355818-F637FB1F-9E20-42E4-90F9-6C978D4F9E7AQ37697113-A7BA39D5-2EF4-4EFD-8CEA-9472097E87D2Q37704872-D0DB422F-138D-47E3-BC1F-4DF4841C230FQ37706741-229402DD-6E64-4902-9EB4-7DD0EFE85B4AQ37735853-59B80A31-D561-4B41-858A-900DEE0D1FD0Q37893109-F0F4C580-EFAC-4B48-81E9-7C981569F44DQ37982868-DEA8D8AA-FA6D-40C0-A59F-F7C830500DB7Q38058329-21FD766A-83C8-4277-B7C6-06933D2FA103Q38412129-68F87182-4A0E-42CF-BF73-A17BDA5482BBQ38515281-AEE9D874-8BAF-499D-9431-6FB0E7B7075BQ38946102-F7C4530F-3EF9-454D-BF2B-CA0E39989B7BQ38982462-D2395A17-F051-4C58-A1FA-0876A091F639Q39278625-99FD8BE8-BB74-4902-93A9-3F947858E9DDQ39942156-2706CB1B-80A6-4335-8ACC-6DE7B45A919EQ40389741-AB4A2FF6-336E-48D9-A9A9-6EE589537E1BQ41204791-B351084E-169C-49C9-A9CC-FB1ECBD28340
P2860
Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Influence of hepatic encephalo ...... fe in patients with cirrhosis.
@en
Influence of hepatic encephalo ...... fe in patients with cirrhosis.
@nl
type
label
Influence of hepatic encephalo ...... fe in patients with cirrhosis.
@en
Influence of hepatic encephalo ...... fe in patients with cirrhosis.
@nl
prefLabel
Influence of hepatic encephalo ...... fe in patients with cirrhosis.
@en
Influence of hepatic encephalo ...... fe in patients with cirrhosis.
@nl
P2093
P921
P356
P1476
Influence of hepatic encephalo ...... fe in patients with cirrhosis.
@en
P2093
Brendan M McGuire
Miguel R Arguedas
Thomas G DeLawrence
P2888
P304
P356
10.1023/A:1024784327783
P577
2003-08-01T00:00:00Z
P6179
1031822066